Literature DB >> 24995226

Primary treatment of kawasaki disease with corticosteroids.

Swati Singhal1, Devendra Mishra2, Sumod Kurien3, Monica Juneja4.   

Abstract

Kawasaki disease (KD), is the leading cause of acquired heart disease in children in the developed world. The use of aspirin and intravenous immunoglobulin as the initial therapy in KD is the standard of care, as they reduce the incidence of coronary artery aneurysms, the major cardiac morbidity from this disease. The place of corticosteroids in the initial therapy is; however, controversial. We describe the course of a one-year-old child with Kawasaki disease who was treated with aspirin and corticosteroids as the initial therapy, and discuss pertinent issues.

Entities:  

Keywords:  Coronary aneurysms; Corticosteroid; Kawasaki disease; Management; Outcome

Year:  2014        PMID: 24995226      PMCID: PMC4080047          DOI: 10.7860/JCDR/2013/7076.4366

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

1.  Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.

Authors:  Shohei Ogata; Yoshihito Ogihara; Takashi Honda; Shinya Kon; Kazumasa Akiyama; Masahiro Ishii
Journal:  Pediatrics       Date:  2011-12-05       Impact factor: 7.124

2.  Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.

Authors:  Tohru Kobayashi; Tsutomu Saji; Tetsuya Otani; Kazuo Takeuchi; Tetsuya Nakamura; Hirokazu Arakawa; Taichi Kato; Toshiro Hara; Kenji Hamaoka; Shunichi Ogawa; Masaru Miura; Yuichi Nomura; Shigeto Fuse; Fukiko Ichida; Mitsuru Seki; Ryuji Fukazawa; Chitose Ogawa; Kenji Furuno; Hirohide Tokunaga; Shinichi Takatsuki; Shinya Hara; Akihiro Morikawa
Journal:  Lancet       Date:  2012-03-08       Impact factor: 79.321

3.  Is there a role for corticosteroids in Kawasaki disease?

Authors:  Stanford T Shulman
Journal:  J Pediatr       Date:  2003-06       Impact factor: 4.406

4.  Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.

Authors:  Angela C Wooditch; Stephen C Aronoff
Journal:  Pediatrics       Date:  2005-10       Impact factor: 7.124

5.  Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children.

Authors:  Yasunori Okada; Makoto Shinohara; Tomio Kobayashi; Yoshinari Inoue; Takeshi Tomomasa; Tohru Kobayashi; Akihiro Morikawa
Journal:  J Pediatr       Date:  2003-09       Impact factor: 4.406

6.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

7.  A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease.

Authors:  Bo-Hui Zhu; Hai-Tao Lv; Ling Sun; Jian-Min Zhang; Lei Cao; Hong-Liang Jia; Wen-Hua Yan; Yue-Ping Shen
Journal:  Eur J Pediatr       Date:  2011-11-05       Impact factor: 3.183

Review 8.  Corticosteroid therapy for primary treatment of Kawasaki disease - weight of evidence: a meta-analysis and systematic review of the literature.

Authors:  Ganesh Athappan; Seth Gale; Thirumalaikolundusubramanian Ponniah
Journal:  Cardiovasc J Afr       Date:  2009 Jul-Aug       Impact factor: 1.167

  8 in total
  1 in total

1.  Intravenous Methylprednisolone Pulse Therapy Versus Intravenous Immunoglobulin in the Prevention of Coronary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial.

Authors:  Nahid Aslani; Seyed-Reza Raeeskarami; Ehsan Aghaei-Moghadam; Fatemeh Tahghighi; Raheleh Assari; Payman Sadeghi; Vahid Ziaee
Journal:  Cureus       Date:  2022-06-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.